⚠ Greater China Oral Care Down by Mid-TeensModerate threat
Procter & Gamble (PG) — threat to the moat
P&G's oral care sales fell by mid-teens in Greater China in fiscal 2026 while its baby care sales there rose about 20%.
The oral care franchise had one bad market in fiscal 2026 and it was a large one. P&G's 10-K says oral care organic sales were flat for the year, with a mid-teens decrease in Greater China1. Greater China is one of P&G's largest international markets; with the UK, Canada, Japan and Germany it makes up about 21% of net sales2.
The 10-K attributes some Health Care volume loss in Greater China to competitive activity3, which means local rivals, not just weak spending. The same market gave P&G its best result elsewhere, a roughly 20% rise in baby care organic sales4, so this is not a China-wide collapse; it is category-specific.
Electric toothbrushes are a discretionary purchase, and the replacement-head annuity only starts once the handle is sold. A lost handle sale in China today is a smaller stream of heads for years.
The weakness carried into the final quarter. Oral care share fell 0.3 points in the June 2026 quarter5, and Health Care organic sales fell 1%6. The decline was not confined to the first half of the year, which makes a quick recovery less likely.
The test is whether fiscal 2027 brings a second year of decline. If Greater China oral care falls again by double digits, the franchise will have lost a meaningful part of its second-largest market to competitors that P&G does not even name.
- ReportedP&G's 10-K says oral care organic sales were flat for the year, with a mid-teens decrease in Greater China.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A and segment note: segment contents, operating segments and shares of net sales and net earnings. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedGreater China is one of P&G's largest international markets; with the UK, Canada, Japan and Germany it makes up about 21% of net sales.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 1 business and Item 2 properties: employees, manufacturing sites, customers, channels, competition and strategy. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedThe 10-K attributes some Health Care volume loss in Greater China to competitive activity, which means local rivals, not just weak spending.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A: market shares and competitive activity by category. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedThe same market gave P&G its best result elsewhere, a roughly 20% rise in baby care organic sales, so this is not a China-wide collapse; it is category-specific.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A: net sales drivers, organic sales and gross margin bridge. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedOral care share fell 0.3 points in the June 2026 quarter, and Health Care organic sales fell 1%.Procter & Gamble fourth-quarter fiscal 2026 earnings slides, Form 8-K exhibit 99.1 - organic sales and core EPS history, share results and fiscal 2027 guidance assumptions. — Q4 FY2026 · publ. 29 July 2026 · source ↗
- ReportedOral care share fell 0.3 points in the June 2026 quarter, and Health Care organic sales fell 1%.Procter & Gamble fourth-quarter and fiscal 2026 results release, Form 8-K exhibit 99.1, with fiscal 2027 guidance - segment results for the quarter and fiscal year. — Q4 FY2026 · publ. 29 July 2026 · source ↗